
|Articles|April 2, 2009
Supplements and Featured Publications
- Cost-Effectiveness and Outcome Optimization Strategies in the Treatment of Residual Cardiovascular R
- Volume 15
- Issue 3
Cost-Effectiveness and Outcome Optimization Strategies in the Treatment of Residual Cardiovascular Risk Beyond LDL Cholesterol in the Managed Care Setting
Advertisement
Articles in this issue
over 16 years ago
Introductionover 16 years ago
Participating Facultyover 16 years ago
The Impact of Residual CVD Risk in the Managed Care SettingNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
House Republicans Block Vote on ACA Subsidy Extension
2
ICYMI: Highlights From the 2025 ASPC Congress on CVD Prevention
3
FDA Approves Rucaparib in BRCA-Mutated mCRPC
4
Higher BMI, IBD Linked to Hidradenitis Suppurativa Risk via Mendelian Randomization
5









































